Results 261 to 270 of about 259,520 (336)
DNA oligos that are used for production of CRISPR/Cas9 trus mutants.
Saeko Takada (21616085) +4 more
openalex +1 more source
This study presents a two‐color FCCS and coincident‐burst analysis platform to quantify actin cargo in dual‐labeled EVs secreted from hiPSCs. The approach tracks secretion dynamics, confirms actin loading, and measures EV size and cargo number, offering insights into cytoskeletal disruption and neuronal differentiation relevant to neurodegenerative ...
Dang Du Nguyen +4 more
wiley +1 more source
CRISPR/Cas9-mediated inactivation of the soybean agglutinin <i>Le1</i> gene to improve grain quality. [PDF]
Kafer JM +8 more
europepmc +1 more source
IGF‐1 deficiency underlies poor ovarian response (POR), as reduced levels in follicular fluid and granulosa cells impair antral follicle formation and compromise reproductive outcomes. Including IGF‐1 as a biomarker significantly enhances the accuracy of models predicting both PORrisk and pregnancy success.
Zhu Hu +9 more
wiley +1 more source
Creating Loss-of-Function Mutants of <i>Neurospora crassa</i> Using a Novel CRISPR/Cas9 System. [PDF]
Grüttner S.
europepmc +1 more source
Highly Secure In Vivo DNA Data Storage Driven by Genomic Dynamics
Integrated computational‐biological programming enables secure in vivo data storage by generating code tables from either genomes or gene regulatory networks, expanding the encryption key space by over 100 orders of magnitude. Storing code tables within synthetic genes, genomes, or gene regulatory networks adds an additional layer of security by ...
Jiaxin Xu +9 more
wiley +1 more source
CRISPR-Cas9-induced double-strand breaks disrupt maintenance of epigenetic information. [PDF]
Wang M, Zhang Y, Bi C, Li M.
europepmc +1 more source
Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 [PDF]
Curiel, David T +5 more
core +1 more source

